BIOMAT Database Logo BIOMAT Database Logo

Monotherapy with pefloxacin in neutropenic febrile patients. 1987

M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Academic Hospital, Maastricht, The Netherlands.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D015366 Pefloxacin A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. 2589 R.B.,Abactal,Peflacine,Pefloxacin Mesylate,Pefloxacin Mesylate Dihydrate,Pefloxacine,Silver Pefloxacin,Dihydrate, Pefloxacin Mesylate,Mesylate Dihydrate, Pefloxacin,Mesylate, Pefloxacin,Pefloxacin, Silver,R.B., 2589

Related Publications

M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Monotherapy for empirical management of febrile neutropenic patients.
January 1990, NCI monographs : a publication of the National Cancer Institute,
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Imipenem/cilastatin monotherapy as salvage treatment in febrile neutropenic patients.
October 1996, Journal of chemotherapy (Florence, Italy),
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Piperacillin-tazobactam as empiric monotherapy in febrile neutropenic patients with haematological malignancies.
August 1997, Journal of chemotherapy (Florence, Italy),
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours.
January 1993, European journal of cancer (Oxford, England : 1990),
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Beta-lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy.
October 1990, The Journal of infectious diseases,
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
March 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients.
January 1996, Infection,
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Prevention of infections in neutropenic patients with pefloxacin.
October 1990, The Journal of antimicrobial chemotherapy,
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
July 1990, Antimicrobial agents and chemotherapy,
M S Daniels-Bosman, and G D Beun, and L L Debrus-Palmans, and G H Blijham
Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients.
March 2000, Annals of hematology,
Copied contents to your clipboard!